341 related articles for article (PubMed ID: 9599813)
1. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
McCarthy DM
Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
4. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group.
Kim JG; Graham DY
Am J Gastroenterol; 1994 Feb; 89(2):203-7. PubMed ID: 8304304
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer.
Matsukawa Y; Aoki M; Nishinarita S; Sawada S; Horie T; Kato K; Kawamura Y; Kawamura F; Arakawa Y; Kurosaka H; Morita K; Ohtsuka E; Oribe M; Nakano M; Kitami Y
Rheumatology (Oxford); 2003 Aug; 42(8):947-50. PubMed ID: 12730504
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
13. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya.
Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA
Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
17. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal antiinflammatory drug-associated gastric ulcers do not require Helicobacter pylori for their development.
Laine L; Marin-Sorensen M; Weinstein WM
Am J Gastroenterol; 1992 Oct; 87(10):1398-402. PubMed ID: 1415094
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
